
The site is temporarily down due to maintenance. Sorry for the inconvenience.
The site is temporarily down due to maintenance. Sorry for the inconvenience.
Quality & Accuracy
Experience
The latest technologies
Speed &
Credibility
₾60.00 Original price was: ₾60.00.₾54.00Current price is: ₾54.00.
Breast carcinoma is one of the most common forms of breast cancer. These tumors often produce mucinous antigens, which are high-molecular-weight glycoproteins. CA 15-3 is a carbohydrate antigen-associated antigen of the breast, which is encoded by the MUC-1 gene.
Carbohydrate antigen is mainly used to monitor breast cancer treatment in the presence of metastases. The marker study is not performed in isolation, but its data are considered in conjunction with clinical, anamnestic, instrumental and laboratory research data. CA 15-3 carbohydrate antigen is also used for postoperative surveillance of invasive breast cancer tumors.
In addition to breast cancer, serum levels of CA 15-3 carbohydrate antigen may be elevated in lung, colon, pancreas, liver, ovarian, cervical, and endometrial cancers.
The main limitation of the study is the fact that in the early stage of the tumor, the increase of the marker is not observed, therefore it is not used for screening.
Serial testing helps detect recurrence early in previously treated stage II and III breast cancer patients.
Elevated levels of CA 15-3 carbohydrate antigen in women at risk of breast cancer recurrence who have previously been treated may indicate disease progression.
In breast cancer monitoring, it may indicate disease progression or regression.
Preliminary preparation:A few hours before conducting the study, the intake of food supplements and multivitamins containing biotin (vitamin B7) should be stopped.
Material for examination:Venous blood
Research method:Electrochemiluminescent immunoassay
Order tests online
Other tests
Testing process
| Purchase a test | Submission of material |
| Results Online | Consult a doctor |
News and promotions
